Miniatura

Fitxers

TFG_QU Prados Moreno, Nerea.pdf (1.56 MB)

Tipus de document

Treball de fi de grau

Data de publicació

2019-06

Llicència de publicació

cc-by-nc-nd (c) Prados, 2019
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/138479

Platinum-based anticancer agents: structure-activity relationship and action mechanism. Research on how to overcome cancer cells resistance

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

Resum

Platinum complexes are drugs that are usually used in chemotherapy to try to kill cancerous cells of all kinds and different types of cancers. Even though there are several platinum drugs approved by the FDA (Food and Drug Administration) and in clinical use, there are still thousands of studies trying to develop new platinum complexes. This is due to the existent resistant mechanisms produced by cancerous cells that inhibit these drugs, and for the several side effects that produce towards the human body. The goal of this study is to recollect all the novel platinum complexes developed over the last ten years and organize then depending on their properties.

Descripció

Treballs Finals de Grau de Química, Facultat de Química, Universitat de Barcelona, Any: 2019, Tutor: Ángel Montaña Pedrero

Matèries

Platí, Quimioteràpia, Càncer, Treballs de fi de grau

Matèries (anglès)

Platinum, Chemotherapy, Càncer, Bachelor's theses

Citació

Col·leccions

Treballs Finals de Grau (TFG) - Química

Citació

PRADOS MORENO, Nerea. Platinum-based anticancer agents: structure-activity relationship and action mechanism. Research on how to overcome cancer cells resistance. [consulta: 21 de gener de 2026]. [Disponible a: https://hdl.handle.net/2445/138479]

Exportar metadades

JSON - METS

Compartir registre